New combo therapy aims to slash deadly leaks after pancreatic surgery
NCT ID NCT07262957
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 13 times
Summary
This study tests whether giving a combination of two medicines (hydrocortisone and octreotide) plus using a patch made from the patient's own tissue can lower the risk of major complications after Whipple surgery for pancreatic cancer. The trial includes 400 high-risk patients whose pancreatic duct is very small. The goal is to prevent dangerous leaks and infections, helping patients recover faster and start cancer treatment sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.